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Waiver of consent in a Trial 
intervention Occurring at Birth—how 
Do Parents Feel?
Wade D. Rich and Anup C. Katheria*
Neonatal Research Institute at Sharp Mary Birch Hospital for Women and Newborns, San Diego, CA, USA
Background: We have previously demonstrated that it is difficult to obtain a represen-
tative subject sample when conducting a randomized controlled trial (RCT) at or near 
the time of birth and obtaining antenatal consent. Waiver of consent has been used in 
neonatal trials, but parents’ reactions to being enrolled in these trials have never been 
reported.
Methods: The parents enrolled in a RCT involving a waiver of consent with a post-deliv-
ery discussion were asked to take part in a brief survey. The survey questions included 
the timing of when parents were informed about the study, and how they felt about their 
infants being included in the study.
results: Forty-nine parents completed the online survey. Sixty-nine percent (n = 34) 
remembered a physician discussing their premature baby with them prior to delivery. 
Thirty-four percent (17) indicated the physician had discussed participation in the study 
prior to delivery. Sixty-nine percent (34) indicated that they had a positive or strongly 
positive feeling about the studies impact on their baby’s health.
conclusion: Our study demonstrates that the majority of responding parents of infants 
who have actually participated in a RCT with a waiver of consent process had a positive 
response, a minority had a neutral response, and none had a slightly negative or highly 
negative response to participation in the study.
Keywords: neonatal resuscitation, waiver of consent, delayed cord clamping, umbilical cord milking, parental 
response
inTrODUcTiOn
Informed consent is a process ensuring that subjects enrolled in a research trial are appropriately 
informed of the risks and benefits. Traditionally, consent is obtained directly from the subjects or 
their parents in the case of minors when they are in a condition to understand the information and 
to participate in the consent process. In trials involving newborns who will receive an intervention 
at or near the time of birth, the process requires approaching families before delivery (antenatal 
consent) or, at least in the United States, obtaining a waiver of consent from a local or regional 
institutional review board. In other places such as Canada, the United Kingdom, and Australia, it 
is possible to obtain a delayed/deferred consent, where the intervention is carried out without con-
sent, and then after birth, the parents are approached to discuss the trial and get permission to use 
their infant’s data. Delayed consent has been used in neonatal trials, where the interventions being 
TaBle 1 | responses to questionnaire.
Did a NICU doctor talk to you before delivery about the possibility of having a premature 
baby?
Yes (69.4%) No (26.5%) Don’t 
remember 
(4.0%)
How did you first learn about your baby’s participation in this study? Beforea 
(20.4%)
Afterb 
(48.9%)
Both  
(14.2%)
Don’t Remember 
(16.3%)
Likert-like questions Strongly 
negative
Negative Neutral Positive Strongly 
positive
Which of the following describes how you feel about your baby’s participation in this study? 0% 0% 28.6% 32.6% 38.8%
What impact do you feel participation in this study had on your infant’s health? 0% 0% 30.6% 40.8% 28.6%
I would consider participation in another trial in the future 0% 0% 30.6% 38.7% 30.6%
How is the person filling out this survey related to the infant in the study? Father 
(18.3%)
Mother 
(79.6%)
Together 
(4.0%)
aBefore—my doctor talked to me before the delivery.
bAfter—my doctor or a member of the team talked to my about the study after delivery.
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studied are both deemed low risk and/or standard of care or 
where antenatal consent would not have been practicable (1–6). 
We recently completed a trial comparing two different methods 
of providing placental transfusion to premature newborns (the 
PREMOD trial) for which a waiver of consent was obtained 
from the local IRB. The two interventions for the trial included 
delayed cord clamping until 45 s after birth and umbilical cord 
milking with the unclamped umbilical cord slowly squeezed or 
milked four times before the cord is clamped. The results of this 
trial have been previously reported (4, 5).
The PREMOD trial was conducted at two tertiary neonatal 
intensive care units in the United States; Sharp Mary Birch 
Hospital for Women and Newborns (SMBHWN) and Loma 
Linda University Medical Center (LLU). The trial was approved 
for waiver by each of the hospital’s Institutional Review Boards. 
Both interventions are standard practice and are considered to 
have minimal risk to the neonate. The study met the 45 CFR 
46.116(c) criteria for delayed consent based on the inability to 
conduct the trial without a waiver and the minimal risk of either 
intervention. Pregnant women, dated by their earliest ultrasound 
or last menstrual period at <32 weeks of gestation, were identi-
fied and recruited from the labor and delivery and antepartum 
floors. When appropriate and feasible (typically when mothers 
were admitted for at least 6 h), antenatal consent was obtained. 
We have previously demonstrated that obtaining only antenatal 
consent would have potentially excluded the sickest children, 
including those who might benefit most from one or the other 
intervention (7, 8). Therefore, in cases, where antenatal consent 
could not be obtained, parents were notified of the intervention 
after the fact by the obstetrician or research team and were 
approached and given the opportunity to allow their baby’s data 
to be used. If consent was withheld, the baby would be removed 
from the study and the data would be destroyed. A short survey 
was developed to explore how parents involved in the PREMOD 
trial felt about the effect of the waivered consent process on their 
baby’s care. The proportion of emergently delivered infants in this 
trial was assessed to validate if there were a representative number 
of infants in a trial done with delayed consent.
MaTerials anD MeThODs
Subjects enrolled in the PREMOD trial were asked by members 
of the research team during routine follow-up phone calls if they 
would be willing to provide their email address so that the parents 
could participate in a blinded survey regarding their participa-
tion in the PREMOD study. The calls were part of the normal 
scheduling of their neurodevelopmental follow-up visits for the 
study. Parents then received an email asking them to participate 
in the current study regarding delayed consent, explaining 
that their answers were anonymous. The blinded survey was 
conducted through an online survey program (SurveyMonkey). 
Investigators had access to responses but did not know who was 
completing the surveys. The survey consisted of seven questions 
and was approved by the Sharp HealthCare Investigational Review 
Board (IRB). Prior to the IRB submission, the survey was revised 
and edited through the Sharp Mary Birch Hospital for Women 
and Newborns Parent Advisory Board. The Parent Advisory 
Board is a committee of parents of former premature infants who 
routinely review Neonatal Research Institute protocols to ensure 
that they are appropriately worded for parents, and the study 
protocols are acceptable trials from a parental perspective. The 
survey was distributed between March 2015 and March 2016. A 
brief description of the trial was included as an introduction to 
the survey, including what the interventions were, and that the 
protocols were performed using delayed consent.
resUlTs
Of the 150 infants who were enrolled in the PREMOD trial at 
our site, 98 parents provided email addresses for the survey. 
Forty-nine parents completed the survey (Table  1). Sixty-nine 
percent remembered a physician discussing their premature baby 
with them prior to delivery, 26% did not believe they had such a 
discussion and 4% did not remember. Thirty-four percent (17) 
indicated the physician had discussed participation in the study 
prior to delivery. Eighty percent (39) of surveys were completed 
by the mother.
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DiscUssiOn
This trial attempts to determine how parents of infants enrolled 
in a trial with waiver of consent feel about the process. In a survey 
of researchers whose primary focus was neonatal resuscita-
tion, Foglia found that an overwhelming majority agreed with 
the statement that “Enrolling subjects for DR studies without 
antenatal informed consent is an acceptable tradeoff between 
respect for persons for enrolled subjects and potential benefit for 
all sick newborns” (9). Some investigators have voiced concerns 
that a disproportionate number of vulnerable, disadvantaged 
families are involved in clinical research (10, 11). In our previous 
investigations, we found just the opposite for studies involving 
antenatal consent. The review of subjects’ time from admission 
to the hospital until delivery demonstrated that at least 15% 
(23/150) delivered within 6 h of admission to the hospital, mak-
ing it unlikely antenatal consent would have been obtained. These 
mothers had few or no antenatal steroids and magnesium and 
were more likely to have limited prenatal care.
Waiver of consent has been used in neonatal trials, where the 
interventions being studied are both deemed low risk and/or 
standard of care. The question of how parents feel about waived 
or delayed consent has not been fully answered. Culbert et  al. 
used sample scenarios in a well-educated population and found 
that parents were less comfortable with delayed or waived consent 
than with a more conventional approach (12). In an exploratory 
trial of opting out compared to conventional consent in a group 
of 44 infants, Rogers et al. found that no significant differences 
between the groups when asked if they had any concern that there 
were risks about which they had not been told (13). A survey by 
Burgess et  al. found that the vast majority of parents were not 
comfortable with physicians making the decision to enroll their 
baby in a trial, but several of these trials compared interventions 
that would not have been considered to be low risk (14). The 
timing of the survey used in this study is unique. Unlike situ-
ations like that of Culbert and Davis, the parents have already 
experienced the waivered consent process of two presumably 
beneficial interventions and were asked for permission to use 
additional data.
In an editorial of the PREMOD trial upon which this ques-
tionnaire was based, Tarnow-Mordi et al. suggested that delayed 
consent is the most appropriate way to conduct future trials 
(15). There is debate as to whether a waiver or deferred consent 
is appropriate in neonatal trials particularly when an interven-
tion is deemed above minimal risk (16). This concern highlights 
the key point as to which interventions would fall in the above 
minimal risk category. It was reassuring that there were no 
parents who had negative or strongly negative feelings about the 
study based on their responses to the survey. In a trial of antenatal 
consent using identical interventions of placental transfusion, 
the parents’ responses were also positive, but many parents did 
not remember being enrolled in the study due to the stressful 
period of delivery. Parents commented that re-approaching them 
after the intervention, as was done in this study, would be helpful 
(17). In our experience, the most important benefit of waiver of 
consent is the opportunity to spend significantly more time in a 
non-stressful environment (after the baby has delivered and has 
been stabilized) and review the study in an manner that allows 
the parent to understand and even recall being in the trial. The 
positive responses from the parents reflect this.
The limitations of this study are the small numbers, which are 
a function of this being a single center neonatal trial completed 
in 1 year, and the limited data set, which was chosen to improve 
return of the survey. Also, because the information in this trial 
depends on parental recall, there is the possibility that what they 
recall does not reflect what actually occurred.
cOnclUsiOn
We have shown previously that without waiver of consent, the 
population studied is not representative of the entire population, 
thus diminishing the scientific validity and generalizability of the 
findings. Institutional Review Boards should accept the lack of 
a negative parental reaction as further evidence that waiver of 
consent is an acceptable option for neonatal trials. It may be also 
worth emphasizing the question of how valid antenatal consent 
really is given the mother’s state of mind. We found that the vast 
majority (70%) of responding parents of infants who actually 
participated in a randomized controlled trial involving waiver 
of consent had a positive feeling about the studies impact on 
their baby’s health. We believe that future neonatal trials should 
continue to use this type of consent for low risk/standard of care 
interventions. Future studies using waiver of consent should also 
continue to follow-up with families to help ensure that our results 
remain consistent.
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